Line 1: |
Line 1: |
− | ==[[Forewords and Introductions]]== | + | ==Myeloid proliferations and neoplasms ([[Myeloid proliferations and neoplasms|Overview Page Link]])== |
− | - [[General Introduction]]
| + | |
− | - [[ICCR datasets: Haemopoietic]]
| + | '''Myeloid precursor lesions''' |
− | ==[[Myeloid proliferations and neoplasms]]==
| + | ''Clonal Haematopoiesis'' |
− | *[[Myeloid precursor lesions]]
| |
− | ''italic'' [[Clonal Haematopoiesis]] | |
− | - [[Introduction]]
| |
| - [[Clonal haematopoiesis]] | | - [[Clonal haematopoiesis]] |
| - [[Clonal cytopenias of undetermined significance]] | | - [[Clonal cytopenias of undetermined significance]] |
− | *[[Myeloproliferative neoplasms]]
| + | |
− | ''italic''[[Myeloproliferative neoplasms]] | + | '''Myeloproliferative neoplasms |
− | - [[Introduction]]
| + | ''Myeloproliferative neoplasms'' |
| - [[Chronic myeloid leukaemia]] | | - [[Chronic myeloid leukaemia]] |
| - [[Chronic neutrophilic leukaemia]] | | - [[Chronic neutrophilic leukaemia]] |
Line 19: |
Line 16: |
| - [[Juvenile myelomonocytic leukaemia]] | | - [[Juvenile myelomonocytic leukaemia]] |
| - [[Myeloproliferative neoplasm, NOS]] | | - [[Myeloproliferative neoplasm, NOS]] |
− | *[[Mastocytosis]]
| + | |
− | - [[Introduction]]
| + | '''Mastocytosis''' |
| - [[Cutaneous mastocytosis]] | | - [[Cutaneous mastocytosis]] |
| - [[Systemic mastocytosis]] | | - [[Systemic mastocytosis]] |
| - [[Mast cell sarcoma]] | | - [[Mast cell sarcoma]] |
− | *[[Myelodysplastic neoplasms]]
| + | |
− | - [[Introduction]]
| + | '''Myelodysplastic neoplasms''' |
− | ''italic''[[Myelodysplastic neoplasms, with defining genetic abnormalities]] | + | ''Myelodysplastic neoplasms, with defining genetic abnormalities'' |
| - [[Myelodysplastic neoplasm with low blasts and 5q deletion]] | | - [[Myelodysplastic neoplasm with low blasts and 5q deletion]] |
| - [[Myelodysplastic neoplasm with low blasts and SF3B1 mutation]] | | - [[Myelodysplastic neoplasm with low blasts and SF3B1 mutation]] |
| - [[Myelodysplastic neoplasm with biallelic TP53 inactivation]] | | - [[Myelodysplastic neoplasm with biallelic TP53 inactivation]] |
− | ''italic''[[Myelodysplastic neoplasms, morphologically defined]] | + | ''Myelodysplastic neoplasms, morphologically defined'' |
| - [[Myelodysplastic neoplasm with low blasts]] | | - [[Myelodysplastic neoplasm with low blasts]] |
| - [[Myelodysplastic neoplasm, hypoplastic]] | | - [[Myelodysplastic neoplasm, hypoplastic]] |
| - [[Myelodysplastic neoplasm with increased blasts]] | | - [[Myelodysplastic neoplasm with increased blasts]] |
− | ''italic''[[Myelodysplastic neoplasms of childhood]] | + | ''Myelodysplastic neoplasms of childhood'' |
| - [[Childhood myelodysplastic neoplasm with low blasts]] | | - [[Childhood myelodysplastic neoplasm with low blasts]] |
| - [[Childhood myelodysplastic neoplasm with increased blasts]] | | - [[Childhood myelodysplastic neoplasm with increased blasts]] |
− | *[[Myelodysplastic/myeloproliferative neoplasms]]
| + | |
− | - [[Introduction]]
| + | '''Myelodysplastic/myeloproliferative neoplasms''' |
| - [[Chronic myelomonocytic leukaemia]] | | - [[Chronic myelomonocytic leukaemia]] |
| - [[Myelodysplastic/myeloproliferative neoplasm with neutrophilia]] | | - [[Myelodysplastic/myeloproliferative neoplasm with neutrophilia]] |
| - [[Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]] | | - [[Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]] |
| - [[Myelodysplastic/myeloproliferative neoplasm, NOS]] | | - [[Myelodysplastic/myeloproliferative neoplasm, NOS]] |
− | *[[Acute myeloid leukaemia]]
| + | |
− | - [[Introduction]]
| + | '''Acute myeloid leukaemia''' |
− | ''italic''[[Acute myeloid leukaemia with defining genetic abnormalities]] | + | ''Acute myeloid leukaemia with defining genetic abnormalities'' |
| - [[Acute promyelocytic leukaemia with PML::RARA fusion]] | | - [[Acute promyelocytic leukaemia with PML::RARA fusion]] |
| - [[Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion]] | | - [[Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion]] |
Line 59: |
Line 56: |
| - [[Acute myeloid leukaemia, myelodysplasia-related]] | | - [[Acute myeloid leukaemia, myelodysplasia-related]] |
| - [[Acute myeloid leukaemia with other defined genetic alterations]] | | - [[Acute myeloid leukaemia with other defined genetic alterations]] |
− | ''italic''[[Acute myeloid leukaemia, defined by differentiation]] | + | ''Acute myeloid leukaemia, defined by differentiation'' |
| - [[Acute myeloid leukaemia with minimal differentiation]] | | - [[Acute myeloid leukaemia with minimal differentiation]] |
| - [[Acute myeloid leukaemia without maturation]] | | - [[Acute myeloid leukaemia without maturation]] |
Line 68: |
Line 65: |
| - [[Acute erythroid leukaemia]] | | - [[Acute erythroid leukaemia]] |
| - [[Acute megakaryoblastic leukaemia]] | | - [[Acute megakaryoblastic leukaemia]] |
− | ''italic''[[Myeloid sarcoma]] | + | ''Myeloid sarcoma'' |
| - [[Myeloid sarcoma]] | | - [[Myeloid sarcoma]] |
− | *[[Myeloid neoplasms, secondary]]
| + | |
− | ''italic''[[Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions]] | + | '''Myeloid neoplasms, secondary''' |
− | - [[Introduction]]
| + | ''Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions'' |
| - [[Myeloid neoplasm post cytotoxic therapy]] | | - [[Myeloid neoplasm post cytotoxic therapy]] |
| - [[Myeloid neoplasms associated with germline predisposition]] | | - [[Myeloid neoplasms associated with germline predisposition]] |
| - [[Myeloid proliferations associated with Down syndrome]] | | - [[Myeloid proliferations associated with Down syndrome]] |
− | *[[Myeloid/lymphoid neoplasms]]
| + | |
− | ''italic''[[Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement]] | + | '''Myeloid/lymphoid neoplasms''' |
− | - [[Introduction]]
| + | ''Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement'' |
| - [[Myeloid/lymphoid neoplasm with PDGFRA rearrangement]] | | - [[Myeloid/lymphoid neoplasm with PDGFRA rearrangement]] |
| - [[Myeloid/lymphoid neoplasm with PDGFRB rearrangement]] | | - [[Myeloid/lymphoid neoplasm with PDGFRB rearrangement]] |
Line 86: |
Line 83: |
| - [[Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]] | | - [[Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]] |
| - [[Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]] | | - [[Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]] |
− | *[[Acute leukaemias of mixed or ambiguous lineage]]
| + | |
− | - [[Introduction]]
| + | '''Acute leukaemias of mixed or ambiguous lineage''' |
− | ''italic''[[Acute leukaemia of ambiguous lineage with defining genetic abnormalities]] | + | ''Acute leukaemia of ambiguous lineage with defining genetic abnormalities'' |
| - [[Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]] | | - [[Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]] |
| - [[Mixed-phenotype acute leukaemia with KMT2A rearrangement]] | | - [[Mixed-phenotype acute leukaemia with KMT2A rearrangement]] |
| - [[Acute leukaemia of ambiguous lineage with other defined genetic alterations ]] | | - [[Acute leukaemia of ambiguous lineage with other defined genetic alterations ]] |
− | ''italic''[[Acute leukaemia of ambiguous lineage, immunophenotypically defined]] | + | ''Acute leukaemia of ambiguous lineage, immunophenotypically defined'' |
| - [[Mixed-phenotype acute leukaemia, B/myeloid]] | | - [[Mixed-phenotype acute leukaemia, B/myeloid]] |
| - [[Mixed-phenotype acute leukaemia, T/myeloid]] | | - [[Mixed-phenotype acute leukaemia, T/myeloid]] |
Line 98: |
Line 95: |
| - [[Acute leukaemia of ambiguous lineage, NOS]] | | - [[Acute leukaemia of ambiguous lineage, NOS]] |
| - [[Acute undifferentiated leukaemia]] | | - [[Acute undifferentiated leukaemia]] |
− | ==[[Histiocytic/Dendritic cell neoplasms]]== | + | ==Histiocytic/Dendritic cell neoplasms ([[Histiocytic/Dendritic cell neoplasms|Overview Page Link]])== |
− | - [[Introduction]]
| + | |
− | *[[Plasmacytoid dendritic cell neoplasms]]
| + | '''Plasmacytoid dendritic cell neoplasms''' |
− | ''italic''[[Plasmacytoid dendritic cell neoplasms]] | + | ''Plasmacytoid dendritic cell neoplasms'' |
| - [[Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] | | - [[Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] |
| - [[Blastic plasmacytoid dendritic cell neoplasm]] | | - [[Blastic plasmacytoid dendritic cell neoplasm]] |
− | *[[Langerhans cell and other dendritic cell neoplasms]]
| + | |
− | ''italic''[[Langerhans cells neoplasms]] | + | '''Langerhans cell and other dendritic cell neoplasms''' |
| + | ''Langerhans cells neoplasms'' |
| - [[Langerhans cell histiocytosis]] | | - [[Langerhans cell histiocytosis]] |
| - [[Langerhans cell sarcoma]] | | - [[Langerhans cell sarcoma]] |
− | ''italic''[[Other dendritic cell neoplasms]] | + | ''Other dendritic cell neoplasms'' |
| - [[Indeterminate dendritic cell tumour]] | | - [[Indeterminate dendritic cell tumour]] |
| - [[Interdigitating dendritic cell sarcoma]] | | - [[Interdigitating dendritic cell sarcoma]] |
− | *[[Histiocyte/macrophage neoplasms]]
| + | |
− | ''italic''[[Histiocytic neoplasms]] | + | '''Histiocyte/macrophage neoplasms''' |
| + | ''Histiocytic neoplasms'' |
| - [[Juvenile xanthogranuloma]] | | - [[Juvenile xanthogranuloma]] |
| - [[Erdheim-Chester disease]] | | - [[Erdheim-Chester disease]] |
Line 118: |
Line 117: |
| - [[ALK-positive histiocytosis]] | | - [[ALK-positive histiocytosis]] |
| - [[Histiocytic sarcoma]] | | - [[Histiocytic sarcoma]] |
− | ==[[B-cell lymphoid proliferations and lymphomas]]== | + | ==B-cell lymphoid proliferations and lymphomas ([[B-cell lymphoid proliferations and lymphomas|Overview Page Link]])== |
− | - [[Introduction to B-cell lymphoproliferative disorders and neoplasms]]
| + | |
− | *[[Tumour like lesions with B-cell predominance]]
| + | '''Tumour like lesions with B-cell predominance''' |
− | - [[Introduction]]
| |
| - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] | | - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] |
| - [[IgG4-related disease]] | | - [[IgG4-related disease]] |
Line 127: |
Line 125: |
| - [[Idiopathic multicentric Castleman disease]] | | - [[Idiopathic multicentric Castleman disease]] |
| - [[KSHV/HHV8-associated multicentric Castleman disease]] | | - [[KSHV/HHV8-associated multicentric Castleman disease]] |
− | *[[Precursor B-cell neoplasms]]
| + | |
− | ''italic''[[B-lymphoblastic leukaemias/lymphomas]] | + | '''Precursor B-cell neoplasms''' |
− | - [[Introduction]]
| + | ''B-lymphoblastic leukaemias/lymphomas'' |
| - [[B-lymphoblastic leukaemia/lymphoma]] | | - [[B-lymphoblastic leukaemia/lymphoma]] |
| - [[B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy]] | | - [[B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy]] |
Line 144: |
Line 142: |
| - [[B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]] | | - [[B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]] |
| - [[B-lymphoblastic leukaemia/lymphoma, NOS]] | | - [[B-lymphoblastic leukaemia/lymphoma, NOS]] |
− | *[[Mature B-cell neoplasms]]
| + | |
− | ''italic''[[Pre-neoplastic and neoplastic small lymphocytic proliferations ]] | + | '''Mature B-cell neoplasms''' |
− | - [[Introduction]]
| + | ''Pre-neoplastic and neoplastic small lymphocytic proliferations '' |
| - [[Monoclonal B-cell lymphocytosis]] | | - [[Monoclonal B-cell lymphocytosis]] |
| - [[Chronic lymphocytic leukaemia/small lymphocytic lymphoma]] | | - [[Chronic lymphocytic leukaemia/small lymphocytic lymphoma]] |
− | ''italic''[[Splenic B-cell lymphomas and leukaemias]] | + | ''Splenic B-cell lymphomas and leukaemias'' |
− | - [[Introduction]]
| |
| - [[Hairy cell leukaemia]] | | - [[Hairy cell leukaemia]] |
| - [[Splenic marginal zone lymphoma]] | | - [[Splenic marginal zone lymphoma]] |
| - [[Splenic diffuse red pulp small B-cell lymphoma]] | | - [[Splenic diffuse red pulp small B-cell lymphoma]] |
| - [[Splenic B-cell lymphoma/leukaemia with prominent nucleoli]] | | - [[Splenic B-cell lymphoma/leukaemia with prominent nucleoli]] |
− | ''italic''[[Lymphoplasmacytic lymphoma]] | + | ''Lymphoplasmacytic lymphoma'' |
| - [[Lymphoplasmacytic lymphoma]] | | - [[Lymphoplasmacytic lymphoma]] |
− | ''italic''[[Marginal zone lymphoma]] | + | ''Marginal zone lymphoma'' |
− | - [[Introduction]]
| |
| - [[Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]] | | - [[Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]] |
| - [[Primary cutaneous marginal zone lymphoma ]] | | - [[Primary cutaneous marginal zone lymphoma ]] |
| - [[Nodal marginal zone lymphoma]] | | - [[Nodal marginal zone lymphoma]] |
| - [[Paediatric nodal marginal zone lymphoma]] | | - [[Paediatric nodal marginal zone lymphoma]] |
− | ''italic''[[Follicular lymphoma]] | + | ''Follicular lymphoma'' |
− | - [[Introduction]]
| |
| - [[In situ follicular B-cell neoplasm]] | | - [[In situ follicular B-cell neoplasm]] |
| - [[Follicular lymphoma]] | | - [[Follicular lymphoma]] |
| - [[Paediatric-type follicular lymphoma]] | | - [[Paediatric-type follicular lymphoma]] |
| - [[Duodenal-type follicular lymphoma]] | | - [[Duodenal-type follicular lymphoma]] |
− | ''italic''[[Cutaneous follicle centre lymphoma]] | + | ''Cutaneous follicle centre lymphoma'' |
| - [[Primary cutaneous follicle centre lymphoma]] | | - [[Primary cutaneous follicle centre lymphoma]] |
− | ''italic''[[Mantle cell lymphoma]] | + | ''Mantle cell lymphoma'' |
− | - [[Introduction]]
| |
| - [[In situ mantle cell neoplasm]] | | - [[In situ mantle cell neoplasm]] |
| - [[Mantle cell lymphoma]] | | - [[Mantle cell lymphoma]] |
| - [[Leukaemic non-nodal mantle cell lymphoma]] | | - [[Leukaemic non-nodal mantle cell lymphoma]] |
− | ''italic''[[Transformations of indolent B-cell lymphomas]] | + | ''Transformations of indolent B-cell lymphomas'' |
− | - [[Introduction]]
| |
| - [[Transformations of indolent B-cell lymphomas]] | | - [[Transformations of indolent B-cell lymphomas]] |
− | ''italic''[[Large B-cell lymphomas]] | + | ''Large B-cell lymphomas'' |
− | - [[Introduction]]
| |
| - [[Diffuse large B-cell lymphoma, NOS]] | | - [[Diffuse large B-cell lymphoma, NOS]] |
| - [[T-cell/histiocyte-rich large B-cell lymphoma]] | | - [[T-cell/histiocyte-rich large B-cell lymphoma]] |
Line 199: |
Line 191: |
| - [[Mediastinal grey zone lymphoma]] | | - [[Mediastinal grey zone lymphoma]] |
| - [[High-grade B-cell lymphoma, NOS]] | | - [[High-grade B-cell lymphoma, NOS]] |
− | ''italic''[[Burkitt lymphoma]] | + | ''Burkitt lymphoma'' |
| - [[Burkitt lymphoma]] | | - [[Burkitt lymphoma]] |
− | ''italic''[[KSHV/HHV8-associated B-cell lymphoid proliferations and lymphomas]] | + | ''KSHV/HHV8-associated B-cell lymphoid proliferations and lymphomas'' |
− | - [[Introduction]]
| |
| - [[Primary effusion lymphoma]] | | - [[Primary effusion lymphoma]] |
| - [[KSHV/HHV8-positive diffuse large B-cell lymphoma]] | | - [[KSHV/HHV8-positive diffuse large B-cell lymphoma]] |
| - [[KSHV/HHV8-positive germinotropic lymphoproliferative disorder]] | | - [[KSHV/HHV8-positive germinotropic lymphoproliferative disorder]] |
− | ''italic''[[Lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation]] | + | ''Lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation'' |
− | - [[Introduction]]
| |
| - [[Hyperplasias arising in immune deficiency/dysregulation]] | | - [[Hyperplasias arising in immune deficiency/dysregulation]] |
| - [[Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation ]] | | - [[Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation ]] |
Line 213: |
Line 203: |
| - [[Lymphomas arising in immune deficiency / dysregulation ]] | | - [[Lymphomas arising in immune deficiency / dysregulation ]] |
| - [[Inborn error of immunity-associated lymphoid proliferations and lymphomas]] | | - [[Inborn error of immunity-associated lymphoid proliferations and lymphomas]] |
− | *[[Hodgkin lymphoma]]
| + | |
− | - [[Introduction]]
| + | '''Hodgkin lymphoma''' |
| - [[Classic Hodgkin lymphoma ]] | | - [[Classic Hodgkin lymphoma ]] |
| - [[Nodular lymphocyte predominant Hodgkin lymphoma]] | | - [[Nodular lymphocyte predominant Hodgkin lymphoma]] |
− | *[[Plasma cell neoplasms and other diseases with paraproteins]]
| + | |
− | - [[Introduction]]
| + | '''Plasma cell neoplasms and other diseases with paraproteins''' |
− | ''italic''[[Monoclonal gammopathies]] | + | ''Monoclonal gammopathies'' |
| - [[Cold agglutinin disease ]] | | - [[Cold agglutinin disease ]] |
| - [[IgM monoclonal gammopathy of undetermined significance]] | | - [[IgM monoclonal gammopathy of undetermined significance]] |
| - [[Non-IgM monoclonal gammopathy of undetermined significance]] | | - [[Non-IgM monoclonal gammopathy of undetermined significance]] |
| - [[Monoclonal gammopathy of renal significance]] | | - [[Monoclonal gammopathy of renal significance]] |
− | ''italic''[[Diseases with monoclonal immunoglobulin deposition]] | + | ''Diseases with monoclonal immunoglobulin deposition'' |
| - [[Immunoglobulin-related (AL) amyloidosis]] | | - [[Immunoglobulin-related (AL) amyloidosis]] |
| - [[Monoclonal immunoglobulin deposition disease]] | | - [[Monoclonal immunoglobulin deposition disease]] |
− | ''italic''[[Heavy chain diseases]] | + | ''Heavy chain diseases'' |
− | - [[Introduction]]
| |
| - [[Mu heavy chain disease]] | | - [[Mu heavy chain disease]] |
| - [[Gamma heavy chain disease]] | | - [[Gamma heavy chain disease]] |
| - [[Alpha heavy chain disease]] | | - [[Alpha heavy chain disease]] |
− | ''italic''[[Plasma cell neoplasms]] | + | ''Plasma cell neoplasms'' |
− | - [[Introduction]]
| + | - [[HAEM5:Plasmacytoma]] |
− | - [[Plasmacytoma]] | |
| - [[Plasma cell myeloma / multiple myeloma]] | | - [[Plasma cell myeloma / multiple myeloma]] |
| - [[Plasma cell neoplasms with associated paraneoplastic syndrome]] | | - [[Plasma cell neoplasms with associated paraneoplastic syndrome]] |
− | ==[[T-cell and NK-cell lymphoid proliferations and lymphomas ]]== | + | ==T-cell and NK-cell lymphoid proliferations and lymphomas ([[T-cell and NK-cell lymphoid proliferations and lymphomas |Overview Page Link]])== |
− | - [[Introduction]]
| + | |
− | *[[Tumour-like lesions with T-cell predominance]]
| + | '''Tumour-like lesions with T-cell predominance''' |
| - [[Kikuchi-Fujimoto disease]] | | - [[Kikuchi-Fujimoto disease]] |
| - [[Autoimmune lymphoproliferative syndrome]] | | - [[Autoimmune lymphoproliferative syndrome]] |
| - [[Indolent T-lymphoblastic proliferation]] | | - [[Indolent T-lymphoblastic proliferation]] |
− | *[[Precursor T-cell neoplasms]]
| + | |
− | ''italic''[[T-lymphoblastic leukaemia / lymphoma]] | + | '''Precursor T-cell neoplasms''' |
| + | ''T-lymphoblastic leukaemia / lymphoma'' |
| - [[T-lymphoblastic leukaemia / lymphoma, NOS]] | | - [[T-lymphoblastic leukaemia / lymphoma, NOS]] |
| - [[Early T-precursor lymphoblastic leukaemia / lymphoma ]] | | - [[Early T-precursor lymphoblastic leukaemia / lymphoma ]] |
− | *[[Mature T-cell and NK-cell neoplasms]]
| + | |
− | ''italic''[[Mature T-cell and NK-cell leukaemias]] | + | '''Mature T-cell and NK-cell neoplasms''' |
− | - [[Introduction]]
| + | ''Mature T-cell and NK-cell leukaemias'' |
| - [[T-prolymphocytic leukaemia]] | | - [[T-prolymphocytic leukaemia]] |
| - [[T-large granular lymphocytic leukaemia]] | | - [[T-large granular lymphocytic leukaemia]] |
Line 256: |
Line 245: |
| - [[Sezary syndrome]] | | - [[Sezary syndrome]] |
| - [[Aggressive NK-cell leukaemia]] | | - [[Aggressive NK-cell leukaemia]] |
− | ''italic''[[Primary cutaneous T-cell lymphoid proliferations and lymphomas]] | + | ''Primary cutaneous T-cell lymphoid proliferations and lymphomas'' |
− | - [[Introduction to primary cutaneous T-cell neoplasms]]
| |
| - [[Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]] | | - [[Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]] |
| - [[Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder]] | | - [[Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder]] |
Line 267: |
Line 255: |
| - [[Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]] | | - [[Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]] |
| - [[Primary cutaneous peripheral T-cell lymphoma, NOS]] | | - [[Primary cutaneous peripheral T-cell lymphoma, NOS]] |
− | ''italic''[[Intestinal T-cell and NK-cell lymphoid proliferations and lymphomas]] | + | ''Intestinal T-cell and NK-cell lymphoid proliferations and lymphomas'' |
− | - [[Introduction]]
| |
| - [[Indolent T-cell lymphoma of the gastrointestinal tract]] | | - [[Indolent T-cell lymphoma of the gastrointestinal tract]] |
| - [[Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract]] | | - [[Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract]] |
Line 274: |
Line 261: |
| - [[Monomorphic epitheliotropic intestinal T-cell lymphoma]] | | - [[Monomorphic epitheliotropic intestinal T-cell lymphoma]] |
| - [[Intestinal T-cell lymphoma, NOS]] | | - [[Intestinal T-cell lymphoma, NOS]] |
− | ''italic''[[Hepatosplenic T-cell lymphoma]] | + | ''Hepatosplenic T-cell lymphoma'' |
| - [[Hepatosplenic T-cell lymphoma]] | | - [[Hepatosplenic T-cell lymphoma]] |
− | ''italic''[[Anaplastic large cell lymphoma]] | + | ''Anaplastic large cell lymphoma'' |
− | - [[Introduction]]
| |
| - [[ALK-positive anaplastic large cell lymphoma]] | | - [[ALK-positive anaplastic large cell lymphoma]] |
| - [[ALK-negative anaplastic large cell lymphoma]] | | - [[ALK-negative anaplastic large cell lymphoma]] |
| - [[Breast implant-associated anaplastic large cell lymphoma]] | | - [[Breast implant-associated anaplastic large cell lymphoma]] |
− | ''italic''[[Nodal T-follicular helper (TFH) cell lymphoma]] | + | ''Nodal T-follicular helper (TFH) cell lymphoma'' |
− | - [[Introduction]]
| |
| - [[Nodal TFH cell lymphoma, angioimmunoblastic-type]] | | - [[Nodal TFH cell lymphoma, angioimmunoblastic-type]] |
| - [[Nodal TFH cell lymphoma, follicular-type]] | | - [[Nodal TFH cell lymphoma, follicular-type]] |
| - [[Nodal TFH cell lymphoma, NOS]] | | - [[Nodal TFH cell lymphoma, NOS]] |
− | ''italic''[[Other peripheral T-cell lymphomas]] | + | ''Other peripheral T-cell lymphomas'' |
| - [[Peripheral T-cell lymphoma, NOS]] | | - [[Peripheral T-cell lymphoma, NOS]] |
− | ''italic''[[EBV-positive NK-cell and T-cell lymphomas]] | + | ''EBV-positive NK-cell and T-cell lymphomas'' |
| - [[EBV-positive nodal T- and NK-cell lymphoma]] | | - [[EBV-positive nodal T- and NK-cell lymphoma]] |
| - [[Extranodal NK/T-cell lymphoma]] | | - [[Extranodal NK/T-cell lymphoma]] |
− | ''italic''[[EBV-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood]] | + | ''EBV-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood'' |
− | - [[Introduction]]
| |
| - [[Severe mosquito bite allergy]] | | - [[Severe mosquito bite allergy]] |
| - [[Hydroa vacciniforme lymphoproliferative disorder]] | | - [[Hydroa vacciniforme lymphoproliferative disorder]] |
| - [[Systemic chronic active EBV disease]] | | - [[Systemic chronic active EBV disease]] |
| - [[Systemic EBV-positive T-cell lymphoma of childhood]] | | - [[Systemic EBV-positive T-cell lymphoma of childhood]] |
− | ==[[Stroma-derived neoplasms of lymphoid tissues]]== | + | ==Stroma-derived neoplasms of lymphoid tissues ([[Stroma-derived neoplasms of lymphoid tissues|Overview Page Link]])== |
− | - [[Introduction]]
| + | |
− | *[[Mesenchymal dendritic cell neoplasms]]
| + | '''Mesenchymal dendritic cell neoplasms''' |
− | ''italic''[[Follicular dendritic cell neoplasms]] | + | ''Follicular dendritic cell neoplasms'' |
| - [[Follicular dendritic cell sarcoma]] | | - [[Follicular dendritic cell sarcoma]] |
| - [[EBV-positive inflammatory follicular dendritic cell sarcoma]] | | - [[EBV-positive inflammatory follicular dendritic cell sarcoma]] |
| - [[Fibroblastic reticular cell tumour]] | | - [[Fibroblastic reticular cell tumour]] |
− | *[[Myofibroblastic tumours]]
| + | |
− | ''italic''[[Myofibroblastic tumour]] | + | '''Myofibroblastic tumours''' |
| + | ''Myofibroblastic tumour'' |
| - [[Intranodal palisaded myofibroblastoma]] | | - [[Intranodal palisaded myofibroblastoma]] |
− | *[[Spleen-specific vascular-stromal tumours]]
| + | |
− | ''italic''[[Splenic vascular-stromal tumours]] | + | '''Spleen-specific vascular-stromal tumours''' |
| + | ''Splenic vascular-stromal tumours'' |
| - [[Littoral cell angioma]] | | - [[Littoral cell angioma]] |
| - [[Splenic hamartoma]] | | - [[Splenic hamartoma]] |
| - [[Sclerosing angiomatoid nodular transformation (SANT) of spleen]] | | - [[Sclerosing angiomatoid nodular transformation (SANT) of spleen]] |
− | ==[[Genetic tumour syndromes]]== | + | ==Genetic tumour syndromes ([[Genetic tumour syndromes|Overview Page Link]])== |
− | - [[Introduction]]
| |
| - [[Fanconi anaemia]] | | - [[Fanconi anaemia]] |
| - [[Bloom syndrome]] | | - [[Bloom syndrome]] |
| - [[Ataxia-telangiectasia syndrome]] | | - [[Ataxia-telangiectasia syndrome]] |
| - [[RASopathies]] | | - [[RASopathies]] |